Group 1 - The company, Weisi Medical, announced on August 27 that it will hold its fourth board meeting and supervisory board meeting on the same date in 2025 to review the proposal for using temporarily idle self-owned funds to purchase financial products [1] - The board approved the use of up to 1.05 billion RMB of idle self-owned funds within 12 months from the date of the board's approval for purchasing bank principal-protected and non-bank financial institution principal-protected financial products, as well as medium to low-risk products with high safety and liquidity [1] - The investment strategy is aimed at ensuring that the company's main business operations are not affected while meeting its operational funding needs [1]